BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Bode AM, Dong Z. Circulating Tumor Cells: Moving Biological Insights into Detection. Theranostics 2017;7:2606-19. [PMID: 28819450 DOI: 10.7150/thno.18588] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer. J Pers Med 2021;11:237. [PMID: 33806972 DOI: 10.3390/jpm11030237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Salvianti F, Costanza F, Sonnati G, Pinzani P. Detection and Characterization of Circulating Tumor Cells by Quantitative Real-Time PCR. Methods Mol Biol 2020;2065:139-51. [PMID: 31578693 DOI: 10.1007/978-1-4939-9833-3_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wolny-Rokicka E, Petrasz P, Krajewski W, Sulimiera Michalak S, Tukiendorf A. Analysis of Serum Markers with Regard to Treatment Procedures in Advanced Stage Prostate Cancer Patients. Med Sci Monit 2020;26:e925860. [PMID: 33326414 DOI: 10.12659/MSM.925860] [Reference Citation Analysis]
4 Yousefi M, Ghaffari P, Nosrati R, Dehghani S, Salmaninejad A, Abarghan YJ, Ghaffari SH. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cell Oncol (Dordr) 2020;43:31-49. [PMID: 31828552 DOI: 10.1007/s13402-019-00470-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. Eur J Cancer 2019;106:133-43. [PMID: 30528798 DOI: 10.1016/j.ejca.2018.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
6 Wang Q, Liu J, Zeng J, Yang Z, Ran F, Wu L, Yang G, Mei Q, Wang X, Chen Q. Determination of miRNA derived from exosomes of prostate cancer via toehold-aided cyclic amplification combined with HRP enzyme catalysis and magnetic nanoparticles. Anal Biochem 2021;630:114336. [PMID: 34400146 DOI: 10.1016/j.ab.2021.114336] [Reference Citation Analysis]
7 Papadaki MA, Sotiriou AI, Vasilopoulou C, Filika M, Aggouraki D, Tsoulfas PG, Apostolopoulou CA, Rounis K, Mavroudis D, Agelaki S. Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy. Cancers (Basel) 2020;12:E1556. [PMID: 32545559 DOI: 10.3390/cancers12061556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Shi J, Li F, Yang F, Dong Z, Jiang Y, Nachira D, Chalubinska-Fendler J, Sio TT, Kawaguchi Y, Takizawa H, Song X, Hu Y, Duan L. The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma. Transl Lung Cancer Res 2021;10:4266-80. [PMID: 35004255 DOI: 10.21037/tlcr-21-896] [Reference Citation Analysis]
9 Rao V US, Arakeri G, Subash A, Bagadia RK, Thakur S, Kudpaje AS, Nayar R, Patil S, Paiva Fonseca F, Gomez RS, Brennan PA. Circulating tumour cells in head and neck cancers: Biological insights. J Oral Pathol Med 2020;49:842-8. [PMID: 32526815 DOI: 10.1111/jop.13075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Visal TH, den Hollander P, Cristofanilli M, Mani SA. Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'? Br J Cancer 2022. [PMID: 35273384 DOI: 10.1038/s41416-022-01768-9] [Reference Citation Analysis]
11 Katopodis P, Anikin V, Kishore U, Carter T, Hall M, Asadi N, Polychronis A, Karteris E. Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery. BMJ Open Respir Res 2021;8:e000917. [PMID: 34493540 DOI: 10.1136/bmjresp-2021-000917] [Reference Citation Analysis]
12 Amintas S, Bedel A, Moreau-Gaudry F, Boutin J, Buscail L, Merlio JP, Vendrely V, Dabernat S, Buscail E. Circulating Tumor Cell Clusters: United We Stand Divided We Fall. Int J Mol Sci 2020;21:E2653. [PMID: 32290245 DOI: 10.3390/ijms21072653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
13 Mentis AA, Grivas PD, Dardiotis E, Romas NA, Papavassiliou AG. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal. Cell Mol Life Sci 2020;77:3671-90. [PMID: 32333084 DOI: 10.1007/s00018-020-03529-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Danova M, Torchio M, Comolli G, Sbrana A, Antonuzzo A, Mazzini G. The role of automated cytometry in the new era of cancer immunotherapy. Mol Clin Oncol 2018;9:355-61. [PMID: 30233791 DOI: 10.3892/mco.2018.1701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
15 Liu C, Xiang X, Han S, Lim HY, Li L, Zhang X, Ma Z, Yang L, Guo S, Soo R, Ren B, Wang L, Goh BC. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer. Cancer Lett 2022;524:91-102. [PMID: 34656690 DOI: 10.1016/j.canlet.2021.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ghaderinia M, Khayamian MA, Abadijoo H, Shalileh S, Faramarzpour M, Zandi A, Simaee H, Abbasvandi F, Esmailinejad MR, Rafizadeh-Tafti S, Jahangiri M, Kordehlachin Y, Ghaffari H, Ansari E, Dabbagh N, Akbari ME, Hoseinpour P, Abdolahad M. Capture-free deactivation of CTCs in the bloodstream; a metastasis suppression method by electrostatic stimulation of the peripheral blood. Biosens Bioelectron 2021;183:113194. [PMID: 33813209 DOI: 10.1016/j.bios.2021.113194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wechsler J. [The liquid biopsies: What is their contribution to the management of cancer?]. Rev Med Interne 2018;39:886-90. [PMID: 29909000 DOI: 10.1016/j.revmed.2018.04.012] [Reference Citation Analysis]
18 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
19 Kryvoshlyk I; ESC “Institute of Biology and Medicine” Taras Shevchenko National University of Kyiv, Ukraine. CIRCULATING TUMOR CELLS: WHERE WE LEFT OFF? Biotechnol acta 2021;14:5-27. [DOI: 10.15407/biotech14.04.005] [Reference Citation Analysis]
20 Ha SM, Kim HK, Kim Y, Noh DY, Han W, Chang JM. Diagnostic performance improvement with combined use of proteomics biomarker assay and breast ultrasound. Breast Cancer Res Treat 2022. [PMID: 35084623 DOI: 10.1007/s10549-022-06527-1] [Reference Citation Analysis]
21 Fan M, Wang F, Wang C. Reflux Precipitation Polymerization: A New Platform for the Preparation of Uniform Polymeric Nanogels for Biomedical Applications. Macromol Biosci 2018;18:1800077. [DOI: 10.1002/mabi.201800077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 Osei-bordom DC, Sachdeva G, Christou N. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Front Med 2022;8:788869. [DOI: 10.3389/fmed.2021.788869] [Reference Citation Analysis]
23 Lim M, Park S, Jeong HO, Park SH, Kumar S, Jang A, Lee S, Kim DU, Cho YK. Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer. Cancers (Basel) 2021;13:5272. [PMID: 34771436 DOI: 10.3390/cancers13215272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Koch C, Joosse SA, Schneegans S, Wilken OJW, Janning M, Loreth D, Müller V, Prieske K, Banys-Paluchowski M, Horst LJ, Loges S, Peine S, Wikman H, Gorges TM, Pantel K. Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients. Cancers (Basel) 2020;12:E442. [PMID: 32069934 DOI: 10.3390/cancers12020442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Ma S, Li X, Wang X, Cheng L, Li Z, Zhang C, Ye Z, Qian Q. Current Progress in CAR-T Cell Therapy for Solid Tumors. Int J Biol Sci 2019;15:2548-60. [PMID: 31754328 DOI: 10.7150/ijbs.34213] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
26 Chen CK, Liao J, Li MS, Khoo BL. Urine biopsy technologies: Cancer and beyond. Theranostics 2020;10:7872-88. [PMID: 32685026 DOI: 10.7150/thno.44634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hussain SH, Huertas CS, Mitchell A, Deman AL, Laurenceau E. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: Trends and prospects. Biosens Bioelectron 2022;197:113770. [PMID: 34768065 DOI: 10.1016/j.bios.2021.113770] [Reference Citation Analysis]
28 Li R, Gong Z, Yi K, Li W, Liu Y, Wang F, Guo S. Efficient Detection and Single-Cell Extraction of Circulating Tumor Cells in Peripheral Blood. ACS Appl Bio Mater 2020;3:6521-8. [DOI: 10.1021/acsabm.0c00957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Yu X, Wu N, Chen F, Wei J, Zhao Y. Engineering microfluidic chip for circulating tumor cells: From enrichment, release to single cell analysis. TrAC Trends in Analytical Chemistry 2019;117:27-38. [DOI: 10.1016/j.trac.2019.03.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
30 Liu Y, Xu H, Li T, Wang W. Microtechnology-enabled filtration-based liquid biopsy: challenges and practical considerations. Lab Chip 2021;21:994-1015. [PMID: 33710188 DOI: 10.1039/d0lc01101k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Shabalina EY, Skorova EY, Chudakova DA, Anikin VB, Reshetov IV, Mynbaev OA, Petersen EV. The matrix-dependent 3D spheroid model of the migration of non-small cell lung cancer: a step towards a rapid automated screening. Front Mol Biosci 2021;8:610407. [PMID: 34422897 DOI: 10.3389/fmolb.2021.610407] [Reference Citation Analysis]
32 Bedin C, Crotti S, D'Angelo E, D'Aronco S, Pucciarelli S, Agostini M. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy. Curr Med Chem 2020;27:4274-94. [PMID: 31060482 DOI: 10.2174/0929867326666190507084839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Vallvé-Juanico J, López-Gil C, Ballesteros A, Santamaria X. Endometrial Stromal Cells Circulate in the Bloodstream of Women with Endometriosis: A Pilot Study. Int J Mol Sci 2019;20:E3740. [PMID: 31370190 DOI: 10.3390/ijms20153740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
34 Xue T, Wang S, Ou G, Li Y, Ruan H, Li Z, Ma Y, Zou R, Qiu J, Shen Z, Wu A. Detection of circulating tumor cells based on improved SERS-active magnetic nanoparticles. Anal Methods 2019;11:2918-28. [DOI: 10.1039/c9ay00646j] [Cited by in Crossref: 18] [Article Influence: 6.0] [Reference Citation Analysis]
35 Chemi F, Mohan S, Guevara T, Clipson A, Rothwell DG, Dive C. Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights. Front Oncol 2021;11:672195. [PMID: 34026650 DOI: 10.3389/fonc.2021.672195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Marples B, Welford SM. Radiation Biology and Circulating Tumor Cells. Int J Radiat Oncol Biol Phys 2018;100:813-5. [PMID: 29485052 DOI: 10.1016/j.ijrobp.2017.09.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Hynes WF, Pepona M, Robertson C, Alvarado J, Dubbin K, Triplett M, Adorno JJ, Randles A, Moya ML. Examining metastatic behavior within 3D bioprinted vasculature for the validation of a 3D computational flow model. Sci Adv 2020;6:eabb3308. [PMID: 32923637 DOI: 10.1126/sciadv.abb3308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
38 Adam-Artigues A, Garrido-Cano I, Carbonell-Asins JA, Lameirinhas A, Simón S, Ortega-Morillo B, Martínez MT, Hernando C, Constâncio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer. Cancers (Basel) 2021;13:2848. [PMID: 34200463 DOI: 10.3390/cancers13112848] [Reference Citation Analysis]
39 Lim M, Park J, Lowe AC, Jeong HO, Lee S, Park HC, Lee K, Kim GH, Kim MH, Cho YK. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC. Theranostics 2020;10:5181-94. [PMID: 32373206 DOI: 10.7150/thno.44693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Underwood JJ, Quadri RS, Kalva SP, Shah H, Sanjeeviah AR, Beg MS, Sutphin PD. Liquid Biopsy for Cancer: Review and Implications for the Radiologist. Radiology 2020;294:5-17. [DOI: 10.1148/radiol.2019182584] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
41 Singh AK, Malviya R. Coagulation and inflammation in cancer: Limitations and prospects for treatment. Biochim Biophys Acta Rev Cancer 2022;:188727. [PMID: 35378243 DOI: 10.1016/j.bbcan.2022.188727] [Reference Citation Analysis]
42 Sardarabadi P, Kojabad AA, Jafari D, Liu CH. Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC). Biosensors (Basel) 2021;11:394. [PMID: 34677350 DOI: 10.3390/bios11100394] [Reference Citation Analysis]
43 Zheng Y, Li Q, Hu W, Liao J, Zheng G, Su M. Whole slide imaging of circulating tumor cells captured on a capillary microchannel device. Lab Chip 2019;19:3796-803. [PMID: 31621763 DOI: 10.1039/c9lc00412b] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Patel DA, Blay J. Seeding metastases: The role and clinical utility of circulating tumour cells. Tumour Biol 2021;43:285-306. [PMID: 34690152 DOI: 10.3233/TUB-210001] [Reference Citation Analysis]
45 de Waal GM, de Villiers WJS, Forgan T, Roberts T, Pretorius E. Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulability. Sci Rep 2020;10:8777. [PMID: 32472080 DOI: 10.1038/s41598-020-65324-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
46 Chen Y, Chen X, Li M, Fan P, Wang B, Zhao S, Yu W, Zhang S, Tang Y, Gao T. A new analytical platform for potential point-of-care testing of circulating tumor cells. Biosens Bioelectron 2021;171:112718. [PMID: 33059165 DOI: 10.1016/j.bios.2020.112718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Löser T. Aspects of tumor progression. Med Hypotheses 2020;144:110157. [PMID: 32763726 DOI: 10.1016/j.mehy.2020.110157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Brisotto G, Guerrieri R, Colizzi F, Steffan A, Montico B, Fratta E. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers. Methods Mol Biol 2021;2292:73-94. [PMID: 33651353 DOI: 10.1007/978-1-0716-1354-2_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Wang Y, Zhang W, Tang X, Wang Y, Fu W, Chang K, Chen M. Target-triggered "signal-off" electrochemical aptasensor assisted by Au nanoparticle-modified sensing platform for high-sensitivity determination of circulating tumor cells. Anal Bioanal Chem 2020;412:8107-15. [PMID: 32929571 DOI: 10.1007/s00216-020-02940-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Hakim M, Kermanshah L, Abouali H, Hashemi HM, Yari A, Khorasheh F, Alemzadeh I, Vossoughi M. Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies. Biophys Rev. [DOI: 10.1007/s12551-022-00944-8] [Reference Citation Analysis]